<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T14:27:36Z</responseDate>
  <request identifier="oai:figshare.com:article/34031516" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34031516</identifier>
        <datestamp>2026-09-30T11:04:32Z</datestamp>
        <setSpec>category_1</setSpec>
        <setSpec>category_4</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_931</setSpec>
        <setSpec>portal_63</setSpec>
        <setSpec>item_type_6</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Computer-Aided Drug Design for Type 2 Diabetes-Related
Enzymes: Polarizable and Nonpolarizable Simulations of Enzyme-Inhibitor
Complexes</dc:title>
          <dc:creator>Esmat Mohammadi (11974181)</dc:creator>
          <dc:creator>Justin A. Lemkul (1372401)</dc:creator>
          <dc:subject>Biophysics</dc:subject>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Information Systems not elsewhere classified</dc:subject>
          <dc:subject>type 2 diabetes</dc:subject>
          <dc:subject>regulating glucose production</dc:subject>
          <dc:subject>less directly coupled</dc:subject>
          <dc:subject>inhibitor complexes carbohydrate</dc:subject>
          <dc:subject>important therapeutic targets</dc:subject>
          <dc:subject>flexibility primarily localized</dc:subject>
          <dc:subject>drude model captures</dc:subject>
          <dc:subject>aided drug design</dc:subject>
          <dc:subject>ligands remain associated</dc:subject>
          <dc:subject>cooperative interaction network</dc:subject>
          <dc:subject>binding regions throughout</dc:subject>
          <dc:subject>based virtual screening</dc:subject>
          <dc:subject>apo enzymes show</dc:subject>
          <dc:subject>whereas ligand binding</dc:subject>
          <dc:subject>candidate inhibitors identified</dc:subject>
          <dc:subject>including pancreatic α</dc:subject>
          <dc:subject>inhibitors identified</dc:subject>
          <dc:subject>representative ligands</dc:subject>
          <dc:subject>regions surrounding</dc:subject>
          <dc:subject>interaction patterns</dc:subject>
          <dc:subject>computational screening</dc:subject>
          <dc:subject>related enzymes</dc:subject>
          <dc:subject>digesting enzymes</dc:subject>
          <dc:subject>small number</dc:subject>
          <dc:subject>results highlight</dc:subject>
          <dc:subject>reference data</dc:subject>
          <dc:subject>quantum mechanical</dc:subject>
          <dc:subject>parametrized using</dc:subject>
          <dc:subject>nonpolarizable charmm</dc:subject>
          <dc:subject>molecular dynamics</dc:subject>
          <dc:subject>largely driven</dc:subject>
          <dc:subject>findings provide</dc:subject>
          <dc:subject>dominant contacts</dc:subject>
          <dc:subject>dependent manner</dc:subject>
          <dc:subject>computational support</dc:subject>
          <dc:subject>catalytic residues</dc:subject>
          <dc:subject>catalytic pockets</dc:subject>
          <dc:subject>catalytic machinery</dc:subject>
          <dc:description>Carbohydrate-digesting
enzymes, including pancreatic α-amylase
and maltase-glucoamylase (MGAM), are important therapeutic targets
for type 2 diabetes due to their role in regulating glucose production.
In this study, molecular dynamics (MD) simulations were performed
to investigate the stability and interaction patterns of inhibitors
identified through SILCS-based virtual screening. Representative ligands
for the N-terminal and C-terminal domains of MGAM (NtMGAM, CtMGAM),
and α-amylase were parametrized using both the nonpolarizable
CHARMM and polarizable Drude force fields based on quantum mechanical
(QM) reference data. MD simulations of the apo enzymes show that their
overall structures remain stable, with flexibility primarily localized
to regions surrounding the catalytic pockets. Simulations of the enzyme–ligand
complexes demonstrate that the ligands remain associated with the
binding regions throughout the trajectories. Comparison between the
two force fields reveals distinct interaction patterns: CHARMM interactions
are largely driven by a small number of dominant contacts, whereas
the Drude model captures a more extensive and cooperative interaction
network. Notably, the Drude model enables enhanced engagement with
catalytic residues in NtMGAM, whereas ligand binding in CtMGAM and
α-amylase remains more flexible and less directly coupled to
the catalytic machinery. These results highlight the importance of
polarization in describing enzyme–ligand interactions and suggest
that polarization can influence the balance and persistence of interactions
in a system-dependent manner. These findings provide further computational
support for the candidate inhibitors identified through computational
screening.</dc:description>
          <dc:date>2026-09-30T00:00:00Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Journal contribution</dc:type>
          <dc:identifier>10.1021/acs.jcim.6c01734.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/journal_contribution/Computer-Aided_Drug_Design_for_Type_2_Diabetes-Related_Enzymes_Polarizable_and_Nonpolarizable_Simulations_of_Enzyme-Inhibitor_Complexes/34031516</dc:relation>
          <dc:rights>CC BY-NC 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
